New Zealand has approved the restricted medicinal use of psilocybin, a hallucinogen found in “magic mushrooms” for patients with treatment-resistant depression.
David Seymour, New Zealand’s associate minister of health, said on Wednesday that the rules have been relaxed on the use of Psilocybin in the country for the first time but only a highly experienced psychiatrist has been allowed to prescribe it to patients.